{
    "nctId": "NCT02411760",
    "briefTitle": "Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection",
    "officialTitle": "Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Diagnostic Improvement Gained using an optimized MR Method for Breast Cancer Detection.",
    "eligibilityCriteria": "Inclusion Criteria:\n\nWomen with Breast Imaging-Reporting and Data System (BI-RADS) 4 or 5 Age \u2265 18 years Ability to understand and the willingness to sign a written informed consent.\n\nExclusion Criteria:\n\nSubjects who have had a needle biopsy of the suspicious area within the last 6 weeks Subjects who have contraindication to contrast enhanced MRI examination.\n\nContraindications to MRI examinations include:\n\nMedically unstable\n\n* Heart failure\n* Unstable angina\n* Child bearing\n* Lactating Any contraindication per MRI Screening Form (Appendix A attached).\n* Implants contraindicated at 3T, pacemakers\n* Poorly controlled diabetes\n* Body weight greater than 300 pounds\n* Claustrophobic Since each patient is receiving a gadolinium based contrast agent intravenously:\n* eGFR \\< 60 mL/min/1.73m2\n* Sickle cell disease\n* Hemolytic anemia\n\nSubjects must not be pregnant or nursing due to the potential for gadolinium contrast agents to harm fetuses or nursing infants.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}